Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 What's new in NAFLD pathogenesis, biomarkers and treatment?

× No keyword cloud information.

1 in total

1. miR-4510 blocks hepatocellular carcinoma development through RAF1 targeting and RAS/RAF/MEK/ERK signalling inactivation.

Authors: Amani Ghousein; Nicola Mosca; Flora Cartier; Justine Charpentier; Jean-William Dupuy; Anne-Aurélie Raymond; Paulette Bioulac-Sage; Christophe F Grosset
Journal: Liver Int Date: 2019-10-31 Impact factor: 5.828

1 in total

17 in total

Review 1. A review on the effect of gut microbiota on metabolic diseases.

Authors: Qiwei Shi; Lingli Dai; Qi Zhao; Xian Zhang
Journal: Arch Microbiol Date: 2022-02-23 Impact factor: 2.552

2. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice.

Authors: Aoxiang Zhuge; Shengjie Li; Pengcheng Lou; Wenrui Wu; Kaiceng Wang; Yin Yuan; Jiafeng Xia; Bo Li; Lanjuan Li
Journal: Microbiol Spectr Date: 2022-06-01

3. Canagliflozin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation through Induction of Autophagy.

Authors: Zhipeng Xu; Wenxin Hu; Bin Wang; Ting Xu; Jianning Wang; Dan Wei
Journal: Yonsei Med J Date: 2022-07 Impact factor: 3.052

Review 4. Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease.

Authors: Chander K Negi; Sabbir Khan; Hubert Dirven; Lola Bajard; Luděk Bláha
Journal: Int J Mol Sci Date: 2021-04-20 Impact factor: 5.923

Review 5. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and Treatment.

Authors: Leen J M Heyens; Dana Busschots; Ger H Koek; Geert Robaeys; Sven Francque
Journal: Front Med (Lausanne) Date: 2021-04-14

6. Complementary and alternative therapies for non-alcoholic fatty liver disease: A Bayesian network meta-analysis protocol.

Authors: Tiefeng Zhang; Duan Han; Tianqi Zhang; Cai Jing; Jianguang Sun
Journal: Medicine (Baltimore) Date: 2021-01-29 Impact factor: 1.817

7. acNASH index to diagnose nonalcoholic steatohepatitis: a prospective derivation and global validation study.

Authors: Xi-Xi Wu; Kenneth I Zheng; Jérôme Boursier; Wah-Kheong Chan; Yusuf Yilmaz; Manuel Romero-Gómez; Mohamed El Kassas; Giovanni Targher; Christopher D Byrne; Zhi-Ming Huang; Ming-Hua Zheng
Journal: EClinicalMedicine Date: 2021-10-01

Review 8. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.

Authors: Qian Ren; Hongya Wang; Yan Zeng; Xia Fang; Mei Wang; Dongze Li; Wei Huang; Yong Xu
Journal: Lipids Health Dis Date: 2022-03-02 Impact factor: 3.876

9. Maternal Exercise Mediates Hepatic Metabolic Programming via Activation of AMPK-PGC1α Axis in the Offspring of Obese Mothers.

Authors: Philipp Kasper; Saida Breuer; Thorben Hoffmann; Christina Vohlen; Ruth Janoschek; Lisa Schmitz; Sarah Appel; Gregor Fink; Christoph Hünseler; Alexander Quaas; Münevver Demir; Sonja Lang; Hans-Michael Steffen; Anna Martin; Christoph Schramm; Martin Bürger; Esther Mahabir; Tobias Goeser; Jörg Dötsch; Eva Hucklenbruch-Rother; Inga Bae-Gartz
Journal: Cells Date: 2021-05-19 Impact factor: 6.600

10. Vitamin A in Nonalcoholic Fatty Liver Disease: A Key Player in an Offside Position?

Authors: Carmen Berasain; Matias A Avila
Journal: Cell Mol Gastroenterol Hepatol Date: 2020-09-21